(Q47745405)

English

Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

0 references

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Torsten Haferlach

11

object named as

T Haferlach

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

Claudia Haferlach

9

object named as

C Haferlach

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

Susanne Schnittger

10

object named as

S Schnittger

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

author name string

A Kohlmann

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

N Nadarajah

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

T Alpermann

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

V Grossmann

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

S Schindela

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

F Dicker

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

A Roller

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

W Kern

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

publication date

20 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

28

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

129-137

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

https://scigraph.springernature.com/pub.10.1038/leu.2013.239

0 references

Regulation of TMPRSS6 by BMP6 and iron in human cells and mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Assessment of minimal residual disease in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Next-generation sequencing - feasibility and practicality in haematology

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Recurring mutations found by sequencing an acute myeloid leukemia genome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

DNMT3A Mutations in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

The origin and evolution of mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Integration of next-generation sequencing into clinical practice: are we there yet?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing data

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Database resources of the National Center for Biotechnology Information

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

MutationTaster evaluates disease-causing potential of sequence alterations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

A method and server for predicting damaging missense mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

A novel hierarchical prognostic model of AML solely based on molecular mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Landscape of TET2 mutations in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2013.239

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47745405&oldid=2169242826"